Common Stock, Shares Authorized of THERALINK TECHNOLOGIES, INC. from Q1 2011 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
THERALINK TECHNOLOGIES, INC. quarterly Common Stock, Shares Authorized history and change rate from Q1 2011 to Q4 2023.
  • THERALINK TECHNOLOGIES, INC. Common Stock, Shares Authorized for the quarter ending 31 Dec 2023 was 100B shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

THERALINK TECHNOLOGIES, INC. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 100B 0 0% 31 Dec 2023 10-Q 20 Feb 2024
Q3 2023 100B 0 0% 30 Sep 2023 10-Q 20 Feb 2024
Q2 2023 100B +88B +733% 30 Jun 2023 10-Q 21 Aug 2023
Q1 2023 100B +88B +733% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 100B 31 Dec 2022 10-Q 21 Feb 2023
Q3 2022 100B 0 0% 30 Sep 2022 10-K 05 Jan 2024
Q2 2022 12B 0 0% 30 Jun 2022 10-Q 21 Aug 2023
Q1 2022 12B 0 0% 31 Mar 2022 10-Q 23 May 2022
Q3 2021 100B +88B +733% 30 Sep 2021 10-K 29 Dec 2022
Q2 2021 12B 0 0% 30 Jun 2021 10-Q 28 Sep 2021
Q1 2021 12B +12B +179900% 31 Mar 2021 10-Q 27 Sep 2021
Q4 2020 12B +12B +179900% 31 Dec 2020 10-Q 27 Sep 2021
Q3 2020 12B 0 0% 30 Sep 2020 10-Q 15 Aug 2022
Q2 2020 12B +7B +140% 30 Jun 2020 10-Q 11 Jun 2021
Q1 2020 6.67M -1.49B -99.6% 31 Mar 2020 10-Q 15 May 2020
Q4 2019 6.67M 0 0% 31 Dec 2019 10-Q 15 May 2020
Q3 2019 12B +11.5B +2300% 30 Sep 2019 10-Q 27 Sep 2021
Q2 2019 5B +4.5B +900% 30 Jun 2019 10-Q 15 Aug 2019
Q1 2019 1.5B +1B +200% 31 Mar 2019 10-Q 15 May 2019
Q4 2018 6.67M -1.49B -99.6% 31 Dec 2018 10-K 25 Mar 2020
Q3 2018 500M 0 0% 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 500M 0 0% 30 Jun 2018 10-Q 14 Aug 2018
Q1 2018 500M 0 0% 31 Mar 2018 10-Q 19 Jun 2018
Q4 2017 1.5B +1B +200% 31 Dec 2017 10-K 01 Apr 2019
Q3 2017 500M 0 0% 30 Sep 2017 10-Q 20 Nov 2017
Q2 2017 500M 0 0% 30 Jun 2017 10-Q 14 Sep 2017
Q1 2017 500M 0 0% 31 Mar 2017 10-Q 22 May 2017
Q4 2016 500M 0 0% 31 Dec 2016 10-K 31 May 2018
Q3 2016 500M 0 0% 30 Sep 2016 10-Q 21 Nov 2016
Q2 2016 500M +50M +11.1% 30 Jun 2016 10-Q 15 Aug 2016
Q1 2016 500M 0 0% 31 Mar 2016 10-Q 16 May 2016
Q4 2015 500M 0 0% 31 Dec 2015 10-K 17 Apr 2017
Q3 2015 500M +50M +11.1% 30 Sep 2015 10-Q 16 Nov 2015
Q2 2015 450M 0 0% 31 May 2015 10-Q 20 Jul 2015
Q1 2015 500M +50M +11.1% 28 Feb 2015 10-Q 20 Oct 2015
Q4 2014 500M +50M +11.1% 31 Dec 2014 10-K 13 Apr 2016
Q3 2014 450M 0 0% 31 Aug 2014 10-Q 14 Oct 2014
Q2 2014 450M +300M +200% 31 May 2014 10-Q 21 Jul 2014
Q1 2014 450M 0 0% 28 Feb 2014 10-K 29 May 2015
Q4 2013 450M +300M +200% 30 Nov 2013 10-Q 14 Jan 2014
Q3 2013 450M +300M +200% 31 Aug 2013 10-Q 17 Oct 2013
Q2 2013 150M 0 0% 31 May 2013 10-Q 31 Jul 2013
Q1 2013 450M +300M +200% 28 Feb 2013 10-K 13 Jun 2014
Q4 2012 150M 0 0% 30 Nov 2012 10-Q 22 Jan 2013
Q3 2012 150M 0 0% 31 Aug 2012 10-Q 15 Oct 2012
Q2 2012 150M 31 May 2012 10-Q 13 Jul 2012
Q1 2012 150M 0 0% 29 Feb 2012 10-K 28 Jun 2013
Q4 2011 150M 30 Nov 2011 10-Q 17 Jan 2012
Q3 2011 150M 31 Aug 2011 10-Q 17 Oct 2011
Q1 2011 150M 28 Feb 2011 10-K 18 May 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.